EAM
STAB

Empery Asset Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Empery Asset Management’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-333,016
Closed -$105K – 84
2022
Q1 		$105K Buy
+333,016
New +$356K 0.49% 30

Other funds holding STAB

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Empery Asset Management's STAB Position: Q2 2022 in Review

Empery Asset Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2022, closing a stake of 333,016 shares — an estimated $105K sold.

Empery Asset Management first reported a position in STAB in Q1 2022 and held it in 1 quarter. The position peaked at $105K in Q1 2022. 35 funds tracked by Wall St. Rank hold STAB as of Q2 2022.

  • Empery Asset Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Empery Asset Management sold 333,016 Statera Biopharma, Inc. Common Stock shares in Q2 2022, an estimated $105K.
  • Empery Asset Management first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Empery Asset Management's Statera Biopharma, Inc. Common Stock position peaked at $105K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2022.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.